EFFECTS OF MELATONIN ON GENETIC HYPERCHOLESTEROLEMIA IN RATS

被引:28
作者
AOYAMA, H
MORI, N
MORI, W
机构
[1] UNIV TOKYO, FAC MED, DEPT PATHOL, ANAT 2, TOKYO 113, JAPAN
[2] UNIV TOKYO, FAC MED, DEPT INTERNAL MED 3, ANAT 2, TOKYO 113, JAPAN
关键词
D O I
10.1016/0021-9150(88)90023-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Administration of the pineal hormone melatonin to genetically hypercholesterolemic rats resulted in a decrease in plasma cholesterol levels and in an improvement of fatty changes of the liver. Thus, the antihyperlipemic effect of melatonin, which was first discovered in hypercholesterolemia produced by short- or long-term administration of glucocorticoids, has now been proved to be rather universal and not simply anti-glucocorticoidal. The mechanism of the decrease of plasma cholesterol levels remains unknown. It was also found that the pathogenesis of this so-called genetic hypercholesterolemia in rats involved biochemical nephrotic changes and histopathological changes in the kidney.
引用
收藏
页码:269 / 272
页数:4
相关论文
共 10 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]  
AOYAMA H, 1987, ACTA PATHOL JAPON, V37, P1143
[3]  
AOYAMA H, 1986, ACTA PATHOL JAPON, V36, P423
[4]  
BUCOLO G, 1973, CLIN CHEM, V19, P476
[5]   ISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES [J].
LERNER, AB ;
CASE, JD ;
TAKAHASHI, Y ;
LEE, TH ;
MORI, W .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1958, 80 (10) :2587-2587
[6]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[7]  
MORI N, UNPUB EFFECTS MELATO
[8]  
MORI W, 1984, JPN J EXP MED, V54, P255
[9]  
OHKUBO A, 1981, CLIN CHEM, V27, P1287
[10]  
TAKAYAMA M, 1977, CLIN CHIM ACTA, V79, P93, DOI 10.1016/0009-8981(77)90465-X